Biotage AB (publ) (STO:BIOT)

Market Cap	8.08B
Revenue (ttm)	2.06B
Net Income (ttm)	284.00M
Shares Out	80.05M
EPS (ttm)	3.55
PE Ratio	28.46
Forward PE	29.51
Dividend	1.65 (1.61%)
Ex-Dividend Date	Apr 26, 2024

Volume	146,513
Average Volume	240,914
Open	102.10
Previous Close	102.20
Day's Range	99.95 - 102.20
52-Week Range	98.75 - 202.20
Beta	0.84
RSI	33.85
Earnings Date	Apr 3, 2025

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicol...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1969
• Employees: 673
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BIOT

Financial Performance

In 2024, Biotage AB's revenue was 2.06 billion, an increase of 10.42% compared to the previous year's 1.86 billion. Earnings were 284.00 million, an increase of 15.45%.